§ 13F · FUND PROFILE
Frazier Life Sciences Management, L.P..
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 38Turnover · — · Q1Filed · May 15, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$77M deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 15, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | MIRM | MIRUM PHARMACEUTICALS INC | 7.68M | $709M | 18.3% | +13% |
| 2 | NAMS | NEWAMSTERDAM PHARMA COMPANY | 16.94M | $542M | 14.0% | ±0% |
| 3 | ERAS | ERASCA INC | 24.68M | $399M | 10.3% | +9% |
| 4 | BBIO | BRIDGEBIO PHARMA INC | 3.45M | $256M | 6.6% | −3% |
| 5 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | 9.87M | $233M | 6.0% | ±0% |
| 6 | MBX | MBX BIOSCIENCES INC | 6.65M | $199M | 5.1% | ±0% |
| 7 | PHAT | PHATHOM PHARMACEUTICALS INC | 12.47M | $139M | 3.6% | ±0% |
| 8 | MAZE | MAZE THERAPEUTICS INC | 4.57M | $136M | 3.5% | ±0% |
| 9 | KRYS | KRYSTAL BIOTECH INC | 481K | $124M | 3.2% | −1% |
| 10 | TRVI | TREVI THERAPEUTICS INC | 9.94M | $119M | 3.1% | −3% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE FRAZIER SIGNAL
AC read
Frazier Life Sciences Management, L.P. is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed